Abstract: The present disclosure provides a display substrate, a display panel and a display apparatus, belonging to the field of display technology. The display substrate includes a base, a plurality of common electrodes and a plurality of common electrode lines, the common electrodes are distributed on the base in an array, the common electrode lines extend along a row direction, and each common electrode line is connected to a corresponding row of common electrodes. The common electrode line is connected to the common electrode through a conductive connection portion, and the conductive connection portion includes conductive structures stacked on top of one another in a plurality of layers. The display substrate can reduce the resistance between the common electrode and the common electrode line, thereby reducing the voltage difference between the common electrodes in the display substrate and improving the uniformity of the common voltage therein.

Abstract: A needle assembly for use with an autonomous ultrasound imaging system includes a needle having a proximal end and a distal end adapted to be inserted into a patient. The needle assembly also includes a needle transducer mounted to an exterior surface of the needle and is electrically coupled to a power source. The needle transducer is configured to receive data signals from the autonomous ultrasound imaging system which contain information relating to a plurality of ultrasound waves generated by an ultrasound probe of the autonomous ultrasound imaging system.

Abstract: A spiral wound membrane module has a brackish water RO or NF membrane combined with a permeate carrier having a narrow spacing between membrane contacting elements. The membrane may have water permeability (A-Value) of at least 8*10?5 cm/s/bar at 25° C. The membrane may have salt diffusion rate (B-Value) of at least 0.5*10?5 cm/s at 25° C. The permeate carrier may have a density of 54 wales per inch or more of a gap between adjacent ribs of 215 um or less. The permeate carrier may have a channel cross-sectional area of 16*10?9 m2 or more. Water is fed to the module at a high feed pressure, for example a pressure of at least 50 bar, optionally up to 120 bar. Retentate may be discharged at a concentration of 100 g/L, 130 g/L, or 150 g/L or more.

Abstract: A micro-displacement amplifying apparatus comprises two sets of asymmetrical amplifying structures; each set of asymmetrical amplifying structure comprises a plurality of asymmetrical amplifying units connected in series by flexible hinges; the asymmetrical amplifying unit is used for amplifying a micro-displacement; the two sets of asymmetrical amplifying structures are in opposite positions and overlap with each other; the input end and output end are coupled to the asymmetrical amplifying unit by a flexible hinge, respectively; the input end is used for inputting the micro-displacement to the asymmetrical amplifying unit, and the output end is used for outputting the amplified displacement; the two contacting input ends are fixed and coupled to each other, and the two contacting output ends are fixed and coupled to each other. The present disclosure further discloses an amplification method of the micro-displacement amplifying apparatus.

Abstract: The present invention belongs to the technical field of mobile transformer substation, and in particular relates to a vehicle-mounted mobile transformer with a position-adjustable lead-out bushing.

Abstract: A multimedia playback method includes: playing first multimedia data, switching from playing the first multimedia data to playing a multimedia frame corresponding to a target starting point of second multimedia data, based on a media switching operation, the second multimedia data including multimedia frames corresponding to a plurality of time points, the plurality of time points including pre-configured P candidate starting points, and the target starting point belonging to the P candidate starting points, and switching, during the playing of the second multimedia data, from playing a first multimedia frame in the second multimedia data to playing a new multimedia frame corresponding to a new starting point, based on a target triggering operation, the first multimedia frame being a multimedia frame played at a moment at which the target triggering operation is performed, and the new starting point being a candidate starting point other than the target starting point. .

Abstract: The present invention relates to the technical field of plant cultivation through artificial light, and particularly provides a light environment method for plant cultivation through full-artificial light to provide a full-artificial light source for plant growth. The light source includes a light wave with a waveband of 620 nm to 760 nm, and the number of photons of the light wave of 620 nm to 760 nm accounts for 64% to 76% of the total number of photons of the light source. Compared with traditional light sources, such as existing fluorescent lamps and high-pressure sodium lamps, the present invention adopting a mode of light source proportion and light source combination can greatly improve the yield of the plant.

Abstract: An image processing method and an image processing model training method and device. The image processing method comprises: obtaining a first original image to be processed (S101), and downsampling and blurring said first original image according to a configured downsampling processing algorithm and blur parameter to obtain a degraded image (S102). In the method, a new photo can be downsampled and blurred to obtain the degraded image similar to an old photo, and a good training sample is provided for the application of machine learning in the old photo restoration technology. An image processing model applied in the old photo restoration technology is trained on the basis of the training sample, so as to obtain the image processing model having stronger restoration capability, and when the old photo is restored by using the image processing model, the restoration efficiency is higher, and the restoration effect is better.

Abstract: The present disclosure discloses a method for preparing lenalidomide. The present disclosure provides a method for preparing lenalidomide I, which comprises the following steps: in a solvent, the lenalidomide intermediate II is reduced with a metal in the presence of an organic acid to obtain the lenalidomide I, wherein the metal is one or more selected from zinc, iron, aluminum and manganese. The preparation method of the disclosure has simple and safe operation, simple post-processing steps, environmental friendliness, high total yield. Moreover, the product obtained in the method has a purity of more than 99.90%, maximum single impurity of less than 0.10%, total heavy metal residue of less than 10 ppm and meet the heavy metal residue standard and API standard. Furthermore, the method has a low production cost and is suitable for industrial production.

Abstract: The present disclosure provides a display substrate, a display panel and a display apparatus, belonging to the field of display technology. The display substrate includes a base, a plurality of common electrodes and a plurality of common electrode lines, the common electrodes are distributed on the base in an array, the common electrode lines extend along a row direction, and each common electrode line is connected to a corresponding row of common electrodes. The common electrode line is connected to the common electrode through a conductive connection portion, and the conductive connection portion includes conductive structures stacked on top of one another in a plurality of layers. The display substrate can reduce the resistance between the common electrode and the common electrode line, thereby reducing the voltage difference between the common electrodes in the display substrate and improving the uniformity of the common voltage therein.

Abstract: The present invention provides a method for promoting plant growth, a plant lamp and application thereof. The method at least includes providing an artificial light source for a growing plant. The light source includes a red light with a peak wavelength of 680-695 nm and a light wave half-width lower than 35 nm; or the light source includes a blue light with a peak wavelength of 410-440 nm and a light wave half-width lower than 35 nm. The plant lamp provides the light source for promoting plant growth. By using the light source in the present invention to irradiate the plant, plant growth is significantly promoted.

Abstract: The invention relates to a machine learning model training method and device and electronic equipment, and relates to the technical field of artificial intelligence.

Abstract: This application discloses a communication system including a master base station and a secondary base station, both connecting with a terminal. In the communication system, the master base station sends a first message to the secondary base station for allocating transmission resources for one or more flows to be transmitted between the secondary base station and a terminal, wherein the first message carries one or both of: identification information of each flow to be transmitted, and information of a data radio bearer (DRB) associated with each flow to be transmitted, then the secondary base station may determine a mapping relationship between a DRB and an admitted flow according to the first message. Moreover, the master base station sends DRB configuration information to the terminal. Therefore, requirements of 5G communication systems for QoS management of information transmission in a dual connectivity scenario can be met.

Abstract: A fulvestrant pharmaceutical composition, a preparation method therefor, and an application thereof are provided. The fulvestrant pharmaceutical composition contains fulvestrant solid particles. The particle size of the fulvestrant solid particles satisfies that Dv(10) is selected from 0.400 micrometers to 6.000 micrometers, Dv(50) is selected from 0.700 micrometers to 6.000 micrometers, and Dv(90) is selected from 1.000 micrometers to 6.000 micrometers, provided that Dv(10) is not 0.400 micrometers, Dv(50) is not 0.700 micrometers, and Dv(90) is not 1.000 micrometers. The fulvestrant pharmaceutical composition has a long-acting sustained release.

Abstract: Provided is use of tectorigenin in the preparation of a medicament for treatment of chicken necrotic enteritis. Using tectorigenin for treating chicken necrotic enteritis can significantly reduce the degree of pathological changes in the intestinal tract of chickens with necrotic enteritis, and has a good therapeutic effect on chicken necrotic enteritis caused by Clostridium perfringens.

Abstract: The present disclosure provides a display substrate, including: a display area and a bonding area positioned on a side of the display area, the bonding area includes a plurality of bonding sub-areas arranged at intervals, the bonding sub-areas are arranged along a direction in which an edge of the display area extends and configured for bonding a chip-on-film, where a first antistatic layer is further arranged on the bonding area, at least a part of the first antistatic layer is positioned between adjacent ones of the bonding sub-areas, and the first antistatic layer is electrically coupled to a reference signal terminal. The present disclosure further provides a display device.

Abstract: The embodiments of the present disclosure provide a method and device for adjusting transmission resource. The method includes: allocating a second transmission resource for a first data based on a time difference, in response to the time difference between a predicted starting moment for a User Equipment (UE) to receive the first data and a starting moment of a preconfigured first transmission resource for receiving the first data being determined greater than or equal to a preset time span, wherein the second transmission resource and the first transmission resource have different time domain resources, and the second transmission resource and the first transmission resource have a same frequency domain resource; and transmitting a notification information to the UE, wherein the notification information is used for notifying the UE to update the first transmission resource to the second transmission resource.

Abstract: Provided is a display substrate including a substrate, wherein the substrate includes a display region and a peripheral region located at the periphery of the display region. A GOA circuit, a first common electrode lead, a first capacitor and at least one first ESD unit are provided in the peripheral region. The GOA circuit includes a plurality of GOA units and STV signal lines electrically connected to at least one GOA unit. The first common electrode lead is connected to the STV signal line through at least one first ESD unit. A first capacitor electrode of the first capacitor is connected to the STV signal line, and a second capacitor electrode of the first capacitor is connected to the first common electrode lead.

Abstract: This application discloses a wireless communication method, a wireless communications apparatus, and a wireless communications system. The wireless communication method includes: receiving, by a terminal, downlink configuration information from a base station, where the downlink configuration information is used to indicate a configuration of a downlink control message, the configuration of the downlink control message includes a format of the downlink control message, and the downlink control message is used to carry service data to be transmitted to the terminal; and receiving, by the terminal, the downlink control message from the base station based on the configuration of the downlink control message.

Abstract: A brivaracetam pharmaceutical composition contains an active pharmaceutical ingredient, a matrix forming agent, and a swelling agent. It has a sustained release effect and has a more flat release curve compared with a common gel skeleton sustained-release preparation, and thus achieves the purposes of reducing the release rate of the medicament, controlling the in vivo effective dosage of the medicament, stabilizing the blood concentration, reducing toxic and side effects and reducing the times of daily administration.